Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label phase 2 study of avasopasem manganese for prevention of severe oral mucositis during cisplatin-based chemoradiotherapy in head and neck cancer
2019-002745-38Phase 2Unknown
- Sponsor
- Galera Therapeutics, Inc.
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of avasopasem manganese in stomatitis, sponsored by Galera Therapeutics, Inc. Primary endpoint: Safety and tolerability. Status: unknown.
02
Drugs
avasopasem manganese
03
Conditions
stomatitis
Beyond the preview
Go deeper on 2019-002745-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002745-38.